|
Volumn 61, Issue 10, 2010, Pages 828-831
|
Omalizumab for therapy-resistant chronic urticaria with angioedema;Omalizumab bei therapierefraktärer chronischer Urtikaria mit Angioödem
|
Author keywords
Angioedema; Chronic urticaria; Combined therapy; Omalizumab; Therapy resistant
|
Indexed keywords
ANTIALLERGIC AGENT;
ANTIINFLAMMATORY AGENT;
DESLORATADINE;
DRUG DERIVATIVE;
HISTAMINE H1 RECEPTOR ANTAGONIST;
IMMUNOGLOBULIN E;
LORATADINE;
MONOCLONAL ANTIBODY;
OMALIZUMAB;
PREDNISOLONE;
ADULT;
ANGIONEUROTIC EDEMA;
ARTICLE;
BLOOD;
CASE REPORT;
CHRONIC DISEASE;
DOSE RESPONSE;
DRUG COMBINATION;
DRUG RESISTANCE;
HUMAN;
IMMUNOLOGY;
LEUKOCYTOSIS;
MALE;
ADULT;
ANGIOEDEMA;
ANTI-ALLERGIC AGENTS;
ANTI-INFLAMMATORY AGENTS;
ANTIBODIES, MONOCLONAL;
CHRONIC DISEASE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG RESISTANCE;
DRUG THERAPY, COMBINATION;
HISTAMINE H1 ANTAGONISTS, NON-SEDATING;
HUMANS;
IMMUNOGLOBULIN E;
LEUKOCYTOSIS;
LORATADINE;
MALE;
PREDNISOLONE;
|
EID: 79952276285
PISSN: 00178470
EISSN: 14321173
Source Type: Journal
DOI: 10.1007/s00105-010-2045-1 Document Type: Conference Paper |
Times cited : (6)
|
References (7)
|